270 related articles for article (PubMed ID: 28884437)
1. Extrapolation of a Brivaracetam Exposure-Response Model from Adults to Children with Focal Seizures.
Schoemaker R; Wade JR; Stockis A
Clin Pharmacokinet; 2018 Jul; 57(7):843-854. PubMed ID: 28884437
[TBL] [Abstract][Full Text] [Related]
2. Brivaracetam Population Pharmacokinetics and Exposure-Response Modeling in Adult Subjects With Partial-Onset Seizures.
Schoemaker R; Wade JR; Stockis A
J Clin Pharmacol; 2016 Dec; 56(12):1591-1602. PubMed ID: 27146213
[TBL] [Abstract][Full Text] [Related]
3. Brivaracetam exposure-response predictions in pediatric patients from age 1 month: Extrapolation of levetiracetam adult-pediatric scaling to brivaracetam.
Schoemaker R; Krauwinkel W; Elshoff JP; Stockis A
Epilepsy Res; 2024 May; 202():107332. PubMed ID: 38518434
[TBL] [Abstract][Full Text] [Related]
4. A systematic review and indirect treatment comparison of perampanel versus brivaracetam as adjunctive therapy in patients with focal-onset seizures with or without secondary generalization.
Trinka E; Tsong W; Toupin S; Patten A; Wilson K; Isojarvi J; James D
Epilepsy Res; 2020 Oct; 166():106403. PubMed ID: 32673969
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of brivaracetam: a new drug to treat epilepsy.
Milovanović JR; Janković SM; Pejčić A; Milosavljević M; Opančina V; Radonjić V; Protrka Z; Kostić M
Expert Opin Pharmacother; 2017 Sep; 18(13):1381-1389. PubMed ID: 28737479
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
[TBL] [Abstract][Full Text] [Related]
7. [Brivaracetam for add-on treatment in focal epilepsy].
Strzelczyk A; Steinig I; Klein KM; Willems LM; Knake S; Rosenow F; Bauer S
Nervenarzt; 2016 Oct; 87(10):1086-1093. PubMed ID: 27389600
[TBL] [Abstract][Full Text] [Related]
8. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
[TBL] [Abstract][Full Text] [Related]
9. Human abuse potential of brivaracetam in healthy recreational central nervous system depressant users.
Schoedel KA; Stockis A; Sellers EM
Epilepsy Behav; 2018 Jan; 78():194-201. PubMed ID: 29153631
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies.
Ben-Menachem E; Mameniškienė R; Quarato PP; Klein P; Gamage J; Schiemann J; Johnson ME; Whitesides J; McDonough B; Eckhardt K
Neurology; 2016 Jul; 87(3):314-23. PubMed ID: 27335114
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of brivaracetam efficacy as monotherapy in adult patients with focal seizures.
Schoemaker R; Wade JR; D'Souza J; Stockis A
Epilepsy Res; 2017 Nov; 137():95-100. PubMed ID: 28982069
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial.
Kwan P; Trinka E; Van Paesschen W; Rektor I; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):38-46. PubMed ID: 24116853
[TBL] [Abstract][Full Text] [Related]
13. Adjunctive brivaracetam in focal and generalized epilepsies: A single-center open-label prospective study in patients with psychiatric comorbidities and intellectual disability.
Foo EC; Geldard J; Peacey C; Wright E; Eltayeb K; Maguire M
Epilepsy Behav; 2019 Oct; 99():106505. PubMed ID: 31493736
[TBL] [Abstract][Full Text] [Related]
14. Treatment with brivaracetam in children - The experience of a pediatric epilepsy center.
Nissenkorn A; Tzadok M; Bar-Yosef O; Ben-Zeev B
Epilepsy Behav; 2019 Dec; 101(Pt A):106541. PubMed ID: 31698260
[TBL] [Abstract][Full Text] [Related]
15. Brivaracetam is superior to levetiracetam in a rat model of post-hypoxic myoclonus.
Tai KK; Truong DD
J Neural Transm (Vienna); 2007; 114(12):1547-51. PubMed ID: 17690949
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in double-blind Phase III studies of brivaracetam as adjunctive therapy of focal seizures: A pooled, post-hoc analysis.
Brandt C; Borghs S; Elmoufti S; Mueller K; Townsend R; de la Loge C
Epilepsy Behav; 2017 Apr; 69():80-85. PubMed ID: 28236727
[TBL] [Abstract][Full Text] [Related]
17. A single-center, open-label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers.
Finnema SJ; Rossano S; Naganawa M; Henry S; Gao H; Pracitto R; Maguire RP; Mercier J; Kervyn S; Nicolas JM; Klitgaard H; DeBruyn S; Otoul C; Martin P; Muglia P; Matuskey D; Nabulsi NB; Huang Y; Kaminski RM; Hannestad J; Stockis A; Carson RE
Epilepsia; 2019 May; 60(5):958-967. PubMed ID: 30924924
[TBL] [Abstract][Full Text] [Related]
18. Can Matching-Adjusted Indirect Comparison Methods Mitigate Placebo Response Differences Among Patient Populations in Adjunctive Trials of Brivaracetam and Levetiracetam?
Swallow E; Fang A; Signorovitch J; Plumb J; Borghs S
CNS Drugs; 2017 Oct; 31(10):899-910. PubMed ID: 28856580
[TBL] [Abstract][Full Text] [Related]
19. Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: relationship to anti-convulsant properties.
Gillard M; Fuks B; Leclercq K; Matagne A
Eur J Pharmacol; 2011 Aug; 664(1-3):36-44. PubMed ID: 21575627
[TBL] [Abstract][Full Text] [Related]
20. Brivaracetam: An Adjunctive Treatment for Partial-Onset Seizures.
Kappes JA; Hayes WJ; Strain JD; Farver DK
J Clin Pharmacol; 2017 Jul; 57(7):811-817. PubMed ID: 28394442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
